Neumora Therapeutics, Inc. (NMRA)
2.555
-0.08
(-3.22%)
USD |
NASDAQ |
Mar 19, 10:56
Neumora Therapeutics Market Cap : 426.91M for March 19, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 818.33B |
| Protalix Biotherapeutics, Inc. | 174.51M |
| Nautilus Biotechnology, Inc. | 337.93M |
| Ventyx Biosciences, Inc. (DELISTED) | 999.02M |
| ProKidney Corp. | 273.18M |
Market Cap Related Metrics
| Price to Book Value | 3.230 |
| Price | 2.555 |
| Earnings Yield | -57.27% |